報價延遲最少15分鐘:2025/11/22 16:44 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.21 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-7.74/-0.72
|
|
企業價值
70.48M
|
| 資產負債 |
|
每股賬面淨值
-1.80
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
7.57M
|
|
每股收益
0.91
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts. |
